SLEEP.ST
Sleep Cycle AB (publ) [SLEEP.ST] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
SLEEP.ST Stock Summary
Top 10 Correlated ETFs
SLEEP.ST
Top 10 Correlated Stocks
SLEEP.ST
In the News
SLEEP.ST Financial details
Company Rating
Strong Buy
Market Cap
719.85M
Income
46.14M
Revenue
236.53M
Book val./share
3.01
Cash/share
6.58
Dividend
6
Dividend %
16.44%
Employees
45
Optionable
No
Shortable
Yes
Earnings
08 Feb 2024
P/E
18.5
Forward P/E
-
PEG
5.49
P/S
3.34
P/B
13.49
P/C
5.26
P/FCF
19.14
Quick Ratio
0.79
Current Ratio
1.24
Debt / Equity
0.26
LT Debt / Equity
0.19
-
-
EPS (TTM)
2.3
EPS next Y
-
EPS next Q
-
EPS this Y
32.56%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-61.73%
Revenue last 5Y
13.99%
Revenue Q/Q
0.57%
EPS Q/Q
-36.59%
-
-
-
-
SMA20
-2.7%
SMA50
2.86%
SMA100
9.09%
Inst Own
-
Inst Trans
-
ROA
18%
ROE
38%
ROC
0.73%
Gross Margin
66%
Oper. Margin
21%
Profit Margin
17%
Payout
355%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
20.0-47.0
52W High
-26.38%
52W Low
+73%
RSI
44
Rel Volume
0.14
Avg Volume
30K
Volume
4.06K
Perf Week
-6.74%
Perf Month
2.06%
Perf Quarter
25.82%
Perf Half Y
70.44%
-
-
-
-
Beta
0.09
-
-
Volatility
0.94%, 0.93%
Prev Close
-1.98%
Price
34.6
Change
0.29%
SLEEP.ST Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 817.84 | 1.06K | 9.79 | 10.81 | 11.65 | |
| Net income per share | 277.62 | 293.62 | 0.43 | 1.72 | 2.28 | |
| Operating cash flow per share | 318.24 | 307.65 | 1.08 | 3.12 | 2.6 | |
| Free cash flow per share | 317.69 | 307.65 | 0.76 | 2.72 | 2.51 | |
| Cash per share | 388.98 | 354.24 | 8.86 | 11.8 | 6.58 | |
| Book value per share | 46.2 | 0.85 | 5.83 | 8.15 | 3.01 | |
| Tangible book value per share | 45.81 | 0.85 | 5.58 | 7.67 | 2.79 | |
| Share holders equity per share | 46.2 | 0.85 | 5.83 | 8.15 | 3.01 | |
| Interest debt per share | 10.07 | 7.08 | 0.14 | 0.22 | 0.84 | |
| Market cap | 11.97M | 11.97M | 1.2B | 852.33M | 782.7M | |
| Enterprise value | -44.97M | -40.25M | 1.03B | 623.66M | 665.15M | |
| P/E ratio | 0.29 | 0.27 | 147.46 | 25.11 | 16.96 | |
| Price to sales ratio | 0.1 | 0.08 | 6.54 | 4 | 3.31 | |
| POCF ratio | 0.25 | 0.26 | 59.53 | 13.85 | 14.85 | |
| PFCF ratio | 0.25 | 0.26 | 84.49 | 15.85 | 15.35 | |
| P/B Ratio | 1.73 | 94.25 | 10.98 | 5.3 | 12.83 | |
| PTB ratio | 1.73 | 94.25 | 10.98 | 5.3 | 12.83 | |
| EV to sales | -0.37 | -0.25 | 5.65 | 2.92 | 2.82 | |
| Enterprise value over EBITDA | -0.97 | -0.71 | 83.48 | 12.59 | 9.37 | |
| EV to operating cash flow | -0.94 | -0.87 | 51.41 | 10.14 | 12.62 | |
| EV to free cash flow | -0.94 | -0.87 | 72.97 | 11.6 | 13.04 | |
| Earnings yield | 3.48 | 3.68 | 0.01 | 0.04 | 0.06 | |
| Free cash flow yield | 3.98 | 3.86 | 0.01 | 0.06 | 0.07 | |
| Debt to equity | 0.2 | 7.18 | 0.02 | 0.03 | 0.26 | |
| Debt to assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.07 | |
| Net debt to EBITDA | -1.23 | -0.92 | -13.18 | -4.62 | -1.66 | |
| Current ratio | 0.94 | 0.99 | 1.85 | 2.07 | 1.32 | |
| Interest coverage | 509.63 | 374.95 | 131.68 | 321.97 | 46.49 | |
| Income quality | 0.92 | 0.82 | 1.95 | 1.39 | 1.14 | |
| Dividend Yield | 3.62 | 4.3 | 0 | 0 | 0.18 | |
| Payout ratio | 1.04 | 1.17 | 0 | 0 | 3.08 | |
| Sales general and administrative to revenue | 0.09 | 0.07 | 0.24 | 0.11 | 0.04 | |
| Research and developement to revenue | 0.1 | 0.1 | 0.13 | 0.12 | 0.14 | |
| Intangibles to total assets | 0 | 0 | 0.02 | 0.03 | 0.02 | |
| Capex to operating cash flow | 0 | 0 | -0.3 | -0.13 | -0.03 | |
| Capex to revenue | 0 | 0 | -0.03 | -0.04 | -0.01 | |
| Capex to depreciation | -0.1 | 0 | -2.9 | -1.48 | -0.12 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 537.2 | 74.79 | 7.54 | 17.76 | 12.41 | |
| ROIC | 4.27 | 22.63 | 0.07 | 0.21 | 0.5 | |
| Return on tangible assets | 0.39 | 0.42 | 0.04 | 0.12 | 0.2 | |
| Graham Net | -203.44 | -204.22 | 3.65 | 5.63 | -0.19 | |
| Working capital | -6.14M | -774K | 100.76M | 147.84M | 49.73M | |
| Tangible asset value | 6.87M | 127K | 104.26M | 151.24M | 56.52M | |
| Net current asset value | -7.07M | -1.19M | 100.76M | 145.21M | 37.98M | |
| Invested capital | 0.2 | 7.18 | 0.02 | 0.03 | 0.26 | |
| Average receivables | 7.53M | 21.42M | 28.28M | 26.85M | 33.96M | |
| Average payables | 2.23M | 4.04M | 8.27M | 11.98M | 14.06M | |
| Average inventory | 0 | 0.5 | 1 | 1 | 0.5 | |
| Days sales outstanding | 44.78 | 63.63 | 57.37 | 42.69 | 66.42 | |
| Days payables outstanding | 24.13 | 109.52 | 86.19 | 91.56 | 40.17 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 8.15 | 5.74 | 6.36 | 8.55 | 5.5 | |
| Payables turnover | 15.13 | 3.33 | 4.24 | 3.99 | 9.09 | |
| Inventory turnover | 0 | 22.58M | 41.31M | 56.62M | 0 | |
| ROE | 6.01 | 346.8 | 0.07 | 0.21 | 0.76 | |
| Capex per share | -0.55 | 0 | -0.32 | -0.39 | -0.09 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 2.77 | 2.77 | 2.87 | 3 | 3.02 | |
| Net income per share | 0.2 | 0.45 | 0.51 | 0.82 | 0.5 | |
| Operating cash flow per share | 0.67 | 0.1 | 0.94 | 0.75 | 0.81 | |
| Free cash flow per share | 0.53 | -0.05 | 0.81 | 0.7 | 0.8 | |
| Cash per share | 11.48 | 11.4 | 5.16 | 5.82 | 6.58 | |
| Book value per share | 7.93 | 8.38 | 1.89 | 2.71 | 3.01 | |
| Tangible book value per share | 7.46 | 7.84 | 1.31 | 2.13 | 2.79 | |
| Share holders equity per share | 7.93 | 8.38 | 1.89 | 2.71 | 3.01 | |
| Interest debt per share | 0.21 | 0.94 | 0.89 | 0.84 | 0.82 | |
| Market cap | 875.98M | 851.64M | 527.21M | 474.49M | 782.7M | |
| Enterprise value | 647.31M | 639.38M | 440.43M | 373.46M | 665.15M | |
| P/E ratio | 54.05 | 23.47 | 12.78 | 7.16 | 19.22 | |
| Price to sales ratio | 15.58 | 15.14 | 9.07 | 7.79 | 12.78 | |
| POCF ratio | 64.79 | 429.91 | 27.68 | 31.08 | 47.64 | |
| PFCF ratio | 82.02 | -826.04 | 32.04 | 33.31 | 48.19 | |
| P/B Ratio | 5.45 | 5.01 | 13.77 | 8.65 | 12.83 | |
| PTB ratio | 5.45 | 5.01 | 13.77 | 8.65 | 12.83 | |
| EV to sales | 11.51 | 11.37 | 7.58 | 6.13 | 10.86 | |
| Enterprise value over EBITDA | 100.44 | 48.81 | 28.41 | 15.96 | 31.4 | |
| EV to operating cash flow | 47.88 | 322.75 | 23.12 | 24.47 | 40.49 | |
| EV to free cash flow | 60.61 | -620.15 | 26.76 | 26.22 | 40.95 | |
| Earnings yield | 0 | 0.01 | 0.02 | 0.03 | 0.01 | |
| Free cash flow yield | 0.01 | 0 | 0.03 | 0.03 | 0.02 | |
| Debt to equity | 0.03 | 0.11 | 0.47 | 0.31 | 0.26 | |
| Debt to assets | 0.01 | 0.06 | 0.09 | 0.08 | 0.07 | |
| Net debt to EBITDA | -35.48 | -16.21 | -5.6 | -4.32 | -5.55 | |
| Current ratio | 2.07 | 1.98 | 1.13 | 1.24 | 1.32 | |
| Interest coverage | 139.19 | 369.67 | 62.12 | 105.29 | 16.13 | |
| Income quality | 2.7 | 0.18 | 1.5 | 0.75 | 1.57 | |
| Dividend Yield | 0 | 0 | 0.27 | 0 | 0 | |
| Payout ratio | 0 | 0 | 13.76 | 0 | 0 | |
| Sales general and administrative to revenue | -0.32 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0.49 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.03 | 0.03 | 0.06 | 0.05 | 0.02 | |
| Capex to operating cash flow | -0.21 | -1.52 | -0.14 | -0.07 | -0.01 | |
| Capex to revenue | -0.05 | -0.05 | -0.04 | -0.02 | 0 | |
| Capex to depreciation | -2.22 | -1.86 | -1.13 | -0.44 | -0.02 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 5.97 | 9.18 | 4.65 | 7.05 | 5.83 | |
| ROIC | 0.02 | 0.04 | 0.14 | 0.18 | 0.11 | |
| Return on tangible assets | 0.01 | 0.03 | 0.05 | 0.08 | 0.05 | |
| Graham Net | 5.48 | 4.63 | -0.93 | -0.85 | -0.19 | |
| Working capital | 147.84M | 152.41M | 19.42M | 36.21M | 49.73M | |
| Tangible asset value | 151.24M | 158.87M | 26.61M | 43.2M | 56.52M | |
| Net current asset value | 145.21M | 137.52M | 5.57M | 23.41M | 37.98M | |
| Invested capital | 0.03 | 0.11 | 0.47 | 0.31 | 0.26 | |
| Average receivables | 22.46M | 34.96M | 39.51M | 35.28M | 39.74M | |
| Average payables | 12.96M | 15M | 13.6M | 12.47M | 13.72M | |
| Average inventory | 15.94M | 0.5 | 15.88M | 15.88M | 0 | |
| Days sales outstanding | 39.93 | 71.93 | 52.74 | 53.95 | 63.14 | |
| Days payables outstanding | 65.6 | 100.23 | 57.83 | 44.28 | 36.3 | |
| Days of inventory on hand | 0 | 0 | 161.08 | 0 | 0 | |
| Receivables turnover | 2.25 | 1.25 | 1.71 | 1.67 | 1.43 | |
| Payables turnover | 1.37 | 0.9 | 1.56 | 2.03 | 2.48 | |
| Inventory turnover | 19.49M | 0 | 0.56 | 0 | 0 | |
| ROE | 0.03 | 0.05 | 0.27 | 0.3 | 0.17 | |
| Capex per share | -0.14 | -0.15 | -0.13 | -0.05 | -0.01 |
SLEEP.ST Frequently Asked Questions
What is Sleep Cycle AB (publ) stock symbol ?
Sleep Cycle AB (publ) is a SE stock and trading under the symbol SLEEP.ST
What is Sleep Cycle AB (publ) stock quote today ?
Sleep Cycle AB (publ) stock price is $34.6 today.
Is Sleep Cycle AB (publ) stock public?
Yes, Sleep Cycle AB (publ) is a publicly traded company.
Company Profile
- Volume Average 30K
- Market Capitalization 719.85M
- Employee 45
- CEO Mr. Erik Jivmark
- Headquarters Gothenburg,SE
- IPO Date 2021-06-08
-
Website
https://www.sleepcycle.com 
Sleep Cycle AB (publ) provides sleep tracking applications in Sweden. The company develops sleep and health-related tracking devices. It offers Sleep Cycle, an autonomous sleep tracking tool that tracks and analyzes sleep patterns. The company was incorporated in 2001 and is headquartered in Gothenburg, Sweden.
